Kefpod o Final Pres

download Kefpod o Final Pres

of 43

Transcript of Kefpod o Final Pres

  • 8/13/2019 Kefpod o Final Pres

    1/43

  • 8/13/2019 Kefpod o Final Pres

    2/43

    Gastrointestinal tract

  • 8/13/2019 Kefpod o Final Pres

    3/43

    Digestive System

    Functions:

    It is involved in

    Ingestion

    Digestion

    Absorption

    Excretion of the food

  • 8/13/2019 Kefpod o Final Pres

    4/43

    Common worldwide bacterial

    disease

    An acute illness associated with

    fever that is most often caused

    by the Salmonella typhibacteria

    Transmitted by the ingestion of

    contaminated food or water

  • 8/13/2019 Kefpod o Final Pres

    5/43

    Typhoid

    Typhoid (Enteric fever) remains endemic in many areas of the

    developing world

    Causes over 26 million infections and over 2,00,000 deaths annually

    Incidence is highest in south-central Asia and South East Asia (over

    100/100 000 cases/year), with the highest burden of disease in

    children aged 2-15 years

    Thaver D. BMJ 2009;338:b1865

    http://localhost/var/www/apps/conversion/tmp/scratch_7//upload.wikimedia.org/wikipedia/commons/5/58/Fievre_typhoide.png
  • 8/13/2019 Kefpod o Final Pres

    6/43

    Typhoid

    Causes:

    Caused by several species of Salmonella: S. typhi, S.

    paratyphi

    The proximate cause in most cases is water or food

    contamination by a human carrier

  • 8/13/2019 Kefpod o Final Pres

    7/43

    Typhoid

    Symptoms Incubation period - 1 to 2 wks

    Duration of the illness - 4 to 6 wks

    The patient experiences poor appetite

    abdominal pain

    headaches

    generalized aches and pains;

    fever, often up to 104 F;

    lethargy (usually only if untreated);

  • 8/13/2019 Kefpod o Final Pres

    8/43

    Some people with typhoid fever develop a rash called "rose

    spots," which are small red spots on the abdomen and

    chest.

    Typhoid

    Symptoms

    http://localhost/var/www/apps/conversion/tmp/scratch_7//upload.wikimedia.org/wikipedia/commons/1/12/Salmonella_typhi_typhoid_fever_PHIL_2215_lores.jpg
  • 8/13/2019 Kefpod o Final Pres

    9/43

    Diagnosis

    A complete blood count (CBC) will show a high number of white blood cells.

    A blood culture during the first week of the fever can show S. typhibacteria.

    Widal test : "O" agglutinin antibody titer 1:80 and "H" 1:160 or "O" 4

    times higher supports a diagnosis of typhoid fever

    Other tests that can help diagnose this condition include:

    ELISA urine test to look for the bacteria that cause Typhoid fever

    Fluorescent antibody study to look for substances that are specific to Typhoid

    bacteria

    Platelet count (platelet count will be low)

    Stool culture

  • 8/13/2019 Kefpod o Final Pres

    10/43

    Complication

    Intestinal hemorrhage

    Intestinal perforation

    Encephalitis

    Metastatic abscesses

    Cholecystitis

    Endocarditis

  • 8/13/2019 Kefpod o Final Pres

    11/43

    Antibiotics and supportive care (IV fluids)

    Prior to the use of antibiotics, the fatality rate was 20%

    With antibiotics and supportive care, mortality has

    been reduced to 1%-2%

    With appropriate antibiotic therapy, there is usually

    improvement within 1-2 days and recovery within 7-10

    days

  • 8/13/2019 Kefpod o Final Pres

    12/43

    Antibiotics are the mainstay of the

    therapy in the management of Typhoid

  • 8/13/2019 Kefpod o Final Pres

    13/43

    Chloramphenicol

    Ampicillin

    Trimethoprim-sulfamethoxazole

    Fluroquinolones like ciprofloxacin, ofloxacin

    Third generation cephalosporins like ceftriaxone

    (injectable)

  • 8/13/2019 Kefpod o Final Pres

    14/43

    Treatment

    Chloramphenicol was the original drug of choice for manyyears.

    Advantages:

    Low cost, wide availability

    Disadvantage:

    Not reduces the relapse rate

    No effect on carrier state

    Not useful for treating MDR s typhi.

    Rare serious side effects

  • 8/13/2019 Kefpod o Final Pres

    15/43

    Fluoroquinolones (ciprofloxacin, ofloxacin, enoxacin,

    and pefloxacin) are a large family of anti-infective drugs

    synthesized around the quinolone core and that

    possess a broad antibacterial spectrum (Congeni 2002).

    Fluoroquinolones effectively penetrate macrophages

    and achieve high concentrations in bile (Miller 2000).

    Fluoroquinolones for treating typhoid and paratyphoid fever (enteric fever) (Review) 10 Copyright 2008 TheCochrane Collaboration. Published by JohnWiley & Sons, Ltd.

  • 8/13/2019 Kefpod o Final Pres

    16/43

  • 8/13/2019 Kefpod o Final Pres

    17/43

    Antibiotics like fluroquinolones and thirdgeneration cephalosporins the mainstay

    of the therapy in the management of

    Typhoid

  • 8/13/2019 Kefpod o Final Pres

    18/43

    MDR strains of S. Typhi, carrying resistance to all

    conventional first-line antibiotics (chloramphenicol, co-

    trimoxazole, and ampicillin or amoxicillin), have become

    highly prevalent in several areas of the world since 1989

    In the Indian subcontinent and China, the frequency of

    these MDR strains ranged from 50% to 80% of all S. Typhiisolates and reached 100% during outbreaks (Lee 2000)

    Fluoroquinolones for treating typhoid and paratyphoid fever (enteric fever) (Review) 10 Copyright 2008 TheCochrane Collaboration. Published by JohnWiley & Sons, Ltd.

  • 8/13/2019 Kefpod o Final Pres

    19/43

    There is decreased susceptibility to drugs

    (Chloramphenicol, Ampicillin, Chloramphenicol,

    Cotrimoxazole & Ciprofloxacin) with consequent

    therapeutic failure

    To complicate further, it is often necessary to commence

    treatment before the results of diagnosis or laboratory

    sensitivity tests for resistance are available

    Threlfall EJ. EID 2008;14[5]:860-

  • 8/13/2019 Kefpod o Final Pres

    20/43

    Incidence of multi-drug resistant [MDR]

    salmonella typhi is as high as 92%

    Krishnan P. IJPM 2009;52[4]:505-8

    Similarly ciprofloxacin resistant enteric fever

    has evolved due to their rampant use Capoor MR. JMM 2007;56:1490-4

  • 8/13/2019 Kefpod o Final Pres

    21/43

    Ciprofloxacin resistant Typhoid isolates

    ..rising incidence in Developed countries

    Incidence of resistance to ciprofloxacin in isolates of S. typhi [UK, 2006]

    %

    Threlfall EJ. EID 2008;14[5]:860-1

    Major concern..Antibacterial Resistance

  • 8/13/2019 Kefpod o Final Pres

    22/43

    Ciprofloxacin resistant Typhoid isolates

    rising incidence confirmed in India

    Characterized by rising MIC levels [>0.25 mcg/ml]

    MIC

    [mcg/ml]>

    S t hi i t t Fl i l

  • 8/13/2019 Kefpod o Final Pres

    23/43

    S. typhi resistance to Fluoroquinolones

    in vitro Study, New Delhi

    Indiscriminate use of the existing therapeutic options forenteric fever has resulted in growing incidence of resistance

    31 ciprofloxacin resistant isolates were evaluated for

    sensitivity to advanced Fluoroquinolones & Azithromycin

    Most of these drugs showed raised MIC levels

    Advanced fluoroquinolones including Gatifloxacin showedresistance

    Capoor MR. JMM 2007;56:1490-4

  • 8/13/2019 Kefpod o Final Pres

    24/43

    Rationale for combination in

    Typhoid fever

  • 8/13/2019 Kefpod o Final Pres

    25/43

    Why Combination ?

    Due to the increasing incidence of resistance of the

    pathogens causing typhoid to the currently used

    therapies , there is a need of Using combination of

    drugs

    The advantage of combination of drugs

    Added synergy of the two drugs

    Faster cure

    Increases success rate

    Increased pt compliance

  • 8/13/2019 Kefpod o Final Pres

    26/43

  • 8/13/2019 Kefpod o Final Pres

    27/43

    Ofloxacin + Cefpodoxime Rationale

    Typhoid or Enteric fever is an endemic infection inIndia

    Fluoroquinolones with their intracellular action and

    longer half life offer quicker defervescence in suchcasesDrug of Choice

    Inadequate or Rampant use of these drugs has

    resulted in increased incidence of plasmid resistanceto DNA gyrase

    Newer advanced fluoroquinolones too are resistant in

    such cases

  • 8/13/2019 Kefpod o Final Pres

    28/43

    Ofloxacin + Cefpodoxime Rationale

    Second-line therapy including Ceftriaxone &

    Cefotaxime require parenteral administration

    Combination with Oral Cephalosporin offers

    complementary site of action taking care of

    resistant organisms when used in INITIALLINEsettings

    Ofl i i T h id

  • 8/13/2019 Kefpod o Final Pres

    29/43

    Ofloxacin in TyphoidClinical efficacy

    Studies by Yousuf (1992), Parry(2007) have demonstrated efficacy of

    Ofloxacin (200 mg or 10 mg/kg twice daily for 7 to 14 days)

    in uncomplicated Typhoid

  • 8/13/2019 Kefpod o Final Pres

    30/43

  • 8/13/2019 Kefpod o Final Pres

    31/43

    9 pts with typhoid fever were given ofloxacin in a

    daily dosage of 400 mg for 10 days

    All patients recovered with no relapses

    No case of Salmonella typhi carriage was recorded.

    According to our results, ofloxacin could beconsidered as one of the alternatives for treating

    typhoid fever

    J P Stahl etal. Pathologiebiologie (1986) Volume: 34, Issue: 5, Pages: 505-507

  • 8/13/2019 Kefpod o Final Pres

    32/43

    3rdgeneration cephalosporin

    Reaches therapeutic concentrations in

    respiratory tract and genitourinary tracts and

    bile (PI)

    C f d i P til

  • 8/13/2019 Kefpod o Final Pres

    33/43

    Cefpodoxime Proxetil

    TyphoidClinical efficacy

    A study from Asian population has reported about

    86% efficacy for cefpodoxime in the treatment of

    typhoid fever.

    In Bangladesh, where typhoid fever is also

    endemic, a clinical trial showed cefpodoxime to be

    highly efficacious in the treatment of typhoid fever

    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Feb. 2008, p. 802803

  • 8/13/2019 Kefpod o Final Pres

    34/43

    Kefpod O

    Composition

    Each tablet of Kefpod O contains

    Cefpodoxime 200 mg + Ofloxacin 200 mg

    Ofl i

  • 8/13/2019 Kefpod o Final Pres

    35/43

    Ofloxacin

    2nd generation fluroquinolone

    BactericidalActs on DNA Gyrase and

    topoisomerase IV

    Broad Spectrum

    S/E profile of ofloxacin is better than other

    fluroquinolones

    Ofl i

  • 8/13/2019 Kefpod o Final Pres

    36/43

    Ofloxacin

    Ofloxacin is widely distributed to body tissues

    Between 65 % & 80% of an administered oral dose

    of ofloxacin is excreted unchanged via the kidneys

    within 48 hrs of dosing

    Usual dose of ofloxacin : 200-400 mg BD for 5-7

    days

    Cefpodoxime Proxetil

  • 8/13/2019 Kefpod o Final Pres

    37/43

    Cefpodoxime Proxetil

    3rdGeneration cephalosporin

    Bactericidalacts on the organisms by inhibiting

    bacterial cell wall synthesis

    Very active against gram positive and gram

    negative organisms

    Has excellent tissue penetration including bile and

    good half life

    The usual dosing is- 200 mg BD for 7-10 days

    C f d i P il

  • 8/13/2019 Kefpod o Final Pres

    38/43

    Cefpodoxime Proxetil

    Expanded spectrum cephalosporins such asCefpodoxime Proxetil shows the promising

    results in the management of typhoid

    Cefpodoxime delivers the desired

    characteristics of an antibiotic and may be the

    treatment of choice for MDR typhoid fever

    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Feb. 2008, p. 802803

    K f d O

  • 8/13/2019 Kefpod o Final Pres

    39/43

    Kefpod O

    Cefpodoxime Proxetil Ofloxacin Benefits

    3rdgeneration

    cephalosporin

    2ndgeneration

    Fluroquinolone

    Complementary different

    site of actions & thereforemore useful in tackling

    resistanceInhibits cell wall synthesis Inhibits nuclear DNA

    gyrase for replication

    Broad spectrum including

    gm-ve organisms

    Broad spectrum involving

    gmve

    Ideal for Typhoid

    Achieve therapeutic

    concentration in bile

    Achieve therapeutic

    concentration in bile

    Target cell concentration

    achieved for immediate &

    sustained efficacy to

    prevent further resistance

    200 mg BD 200 mg BD for Typhoid Complementary BD dosage

    Compatible Pharmacokinetic

  • 8/13/2019 Kefpod o Final Pres

    40/43

    Side Effects

    Nausea, Vomiting, GI disturbances

    Drug Interactions

    Antacid, Theophylline, Warfarin

  • 8/13/2019 Kefpod o Final Pres

    41/43

    Indication :

    Typhoid fever

    Dosage:

    1 tablet to be taken twice daily after meals for 7-

    14 days depending upon the severity of

    infections

    USP OF Combination of Cefpodoxime and

  • 8/13/2019 Kefpod o Final Pres

    42/43

    USP OF Combination of Cefpodoxime and

    Ofloxacin

    Synergistic effects of the drugs

    Faster cure

    Better success rate

    Less chances of relapse

    Less chances of Carrier stage

    Better patient compliancethe patient has to take only

    one tablet as against 2 separately

    USP OF Combination of Cefpodoxime and

  • 8/13/2019 Kefpod o Final Pres

    43/43

    USP OF Combination of Cefpodoxime and

    Ofloxacin

    The combination would have good potential and

    would be useful addition for the physician in the

    treatment of typhoid including MDR Typhoid